News

Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second ...
A nonprofit run by Anne Wojcicki, the cofounder and former CEO of 23andme, has agreed to buy the genetic testing company for ...
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...
23andMe's co-founder and former chief executive, Anne Wojcicki, looks set to regain control of the business after emerging ...
Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...
After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy ...
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.
Me (OTC:MEHCQ) faces a second auction after a $305M bid challenges Regeneron's (REGN) initial bid for its assets. Read more ...
Former CEO Anne Wojcicki has prevailed in the bankruptcy auction of 23andMe, its consumer and biopharma research businesses, ...
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...
Added to that, 23andMe suffered a massive data breach in 2023 that resulted in information from about 7 million people being ...